About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Asthma Clinical Trials in Philadelphia | 143 Studies

Clinical Trials AsthmaPhiladelphia

Asthma Clinical Trials in Philadelphia

Find 143 clinical trials for asthma near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Asthma trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 143 trials

CompletedStudy to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaPhase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dependent AsthmaNCT03406078·Bakersfield, California and 59 others

Asthma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.This study aimed to determine the efficacy and safety of QAW039 and QAW039 450 mg compared to placebo, when added to GINA (Global Initiative for Asthma) steps 4 and 5 standard-of-…NCT02563067·Little Rock, Arkansas and 162 others

Active not recruitingStudy of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaThis is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.NCT06676319·Saraland, Alabama and 220 others

TerminatedSafety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease ModificationThis study consists of a 3-year double-blind phase during which patients will receive atopic dermatitis (AD) treatment either with pimecrolimus cream 1% long-term management (LTM)…NCT00124709·Birmingham, Alabama and 35 others

CompletedComparison of Two Medication Adherence Strategies to Improve Asthma Treatment AdherenceThis is a randomized, controlled study that will compare two medication adherence strategies in adults with moderate or severe persistent asthma as a method for improving or…NCT00115323·Philadelphia, Pennsylvania

CompletedA 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With AsthmaThis purpose of this study is to show the superiority and long term safety and efficacy of adding a long acting beta agonist (salmeterol) to constant dose of an inhaled…NCT00452348·Birmingham, Alabama and 80 others

CompletedA Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.The purpose of this study is to determine the effectiveness and safety of SYMBICORT® pMDI (a medication approved by the Food and Drug Administration, FDA) in the African American…NCT00419952·Birmingham, Alabama and 121 others

CompletedA Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsThe primary objective of this study is to evaluate the dose response, efficacy and safety of 4 different doses of fluticasone propionate (50, 100, 200, and 400mcg) delivered as…NCT01576718·Birmingham, Alabama and 299 others

RecruitingA Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaThis Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma.NCT07323654·Lancaster, California and 70 others

CompletedOpen Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.The primary objective of this study is to assess the immunogenic potential of the liquid formulation of omalizumab administered over a period of 6 months in moderate to severe…NCT00500539·Scottsdale, Arizona and 30 others

CompletedEducational Video for Improving Follow-up After an Emergency Department Visit for AsthmaThe study will assess the efficacy of a three-part Emergency Department (ED)-based "Asthma Belief and Control" intervention on healthcare utilization, asthma controller medication…NCT00113633·Philadelphia, Pennsylvania

CompletedVariations in the Composition of Respiratory MicrobiotaInduced sputum samples were obtained from 27 asthmatic patients and 27 non-asthmatic subjects.NCT04747184·Amman

CompletedObservational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)The CHRONICLE Study is a multi-center, non-interventional, prospective cohort study of adults with severe asthma who do not achieve control with high-dose inhaled corticosteroid…NCT03373045·Birmingham, Alabama and 174 others

Active not recruitingInvestigating Dupilumab's Effect in Asthma by GenotypeThe Goal of this study is to investigate if individuals ages 12 years and older, carrying the IL-4RαR576 gene variant, will have a greater response to therapy acting directly on…NCT03694158·Boston, Massachusetts and 5 others

CompletedA Patient Advocate to Improve Real-world Asthma Management for Inner City AdultsFew interventions to improve asthma management have targeted low-income minority asthmatic adults and even fewer have focused on the real-world practice where care is provided for…NCT01972308·Philadelphia, Pennsylvania

CompletedA Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic PhenotypeThis study will assess whether switching participants who have benefitted from mepolizumab or benralizumab to GSK3511294 (Depemokimab) is non-inferior to maintaining current…NCT04718389·Birmingham, Alabama and 396 others

CompletedAn Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled AsthmaPrimary Objective: To evaluate the efficacy of different doses and regimens of dupilumab in participants with moderate to severe uncontrolled asthma.NCT01854047·Fullerton, California and 200 others

CompletedPatient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma REliefAsthma imposes a significant burden in the US in terms of morbidity, costs to society, individual suffering, loss of productivity and mortality.NCT02995733·Birmingham, Alabama and 19 others

CompletedComparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With AsthmaThe purpose of this study is to compare the efficacy and safety of the fixed combination asthma drug FlutiForm HFA MDI with its two components administered alone, fluticasone…NCT00393991·Pell City, Alabama and 56 others

CompletedStudy Of Patients With Allergic Rhinitis And AsthmaThis study will last up to 6 weeks. Subjects will visit the clinic up to 5 times.NCT00296530·Ozark, Alabama and 79 others

PreviousPage 3 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia